Dolby Laboratories, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Dolby Laboratories, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q2 2010 to Q3 2024.
  • Dolby Laboratories, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending September 27, 2024 was $2.49B, a 4.84% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.49B +$115M +4.84% Sep 27, 2024 10-K 2024-11-19
Q2 2024 $2.45B +$64.7M +2.72% Jun 28, 2024 10-Q 2024-08-07
Q1 2024 $2.44B +$81.7M +3.47% Mar 29, 2024 10-Q 2024-08-07
Q4 2023 $2.36B +$69.8M +3.04% Dec 29, 2023 10-Q 2024-05-02
Q3 2023 $2.37B +$121M +5.38% Sep 29, 2023 10-K 2024-11-19
Q2 2023 $2.38B -$76.8M -3.12% Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $2.36B -$249M -9.57% Mar 31, 2023 10-Q 2024-08-07
Q4 2022 $2.29B -$350M -13.2% Dec 30, 2022 10-Q 2024-05-02
Q3 2022 $2.25B -$353M -13.6% Sep 30, 2022 10-K 2024-11-19
Q2 2022 $2.46B -$168M -6.4% Jul 1, 2022 10-Q 2023-08-03
Q1 2022 $2.61B +$11M +0.42% Apr 1, 2022 10-Q 2023-08-03
Q4 2021 $2.64B +$71.3M +2.77% Dec 31, 2021 10-Q 2023-05-05
Q3 2021 $2.6B +$166M +6.8% Sep 24, 2021 10-K 2024-11-19
Q2 2021 $2.63B +$191M +7.83% Jun 25, 2021 10-Q 2022-08-09
Q1 2021 $2.59B +$225M +9.49% Mar 26, 2021 10-Q 2022-08-09
Q4 2020 $2.57B +$233M +9.94% Dec 25, 2020 10-Q 2022-05-05
Q3 2020 $2.44B +$125M +5.42% Sep 25, 2020 10-K 2023-11-17
Q2 2020 $2.44B +$117M +5.03% Jun 26, 2020 10-Q 2021-07-29
Q1 2020 $2.37B +$16.4M +0.7% Mar 27, 2020 10-Q 2021-07-29
Q4 2019 $2.34B -$10.3M -0.44% Dec 27, 2019 10-Q 2021-05-04
Q3 2019 $2.31B -$57.5M -2.43% Sep 27, 2019 10-K 2022-11-18
Q2 2019 $2.32B -$65.4M -2.74% Jun 28, 2019 10-Q 2020-08-03
Q1 2019 $2.35B -$78.9M -3.25% Mar 29, 2019 10-Q 2020-08-03
Q4 2018 $2.35B +$9.83M +0.42% Dec 28, 2018 10-Q 2020-05-04
Q3 2018 $2.37B -$28.2M -1.18% Sep 28, 2018 10-K 2021-11-17
Q2 2018 $2.39B +$263M +12.4% Jun 29, 2018 10-Q 2019-08-02
Q1 2018 $2.43B +$389M +19% Mar 30, 2018 10-Q 2019-08-02
Q4 2017 $2.34B +$338M +16.9% Dec 29, 2017 10-Q 2019-02-01
Q3 2017 $2.4B +$170M +7.62% Sep 29, 2017 10-K 2020-11-16
Q2 2017 $2.12B +$182M +9.38% Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $2.04B +$189M +10.2% Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $2B +$188M +10.4% Dec 30, 2016 10-Q 2018-01-31
Q3 2016 $2.23B +$413M +22.7% Sep 30, 2016 10-K 2019-11-25
Q2 2016 $1.94B +$100M +5.45% Jul 1, 2016 10-Q 2017-08-03
Q1 2016 $1.85B +$55M +3.06% Apr 1, 2016 10-Q 2017-05-03
Q4 2015 $1.81B +$61.1M +3.49% Jan 1, 2016 10-Q 2017-02-02
Q3 2015 $1.82B +$84.4M +4.87% Sep 25, 2015 10-K 2018-11-15
Q2 2015 $1.84B +$154M +9.12% Jun 26, 2015 10-Q 2016-08-02
Q1 2015 $1.8B +$146M +8.82% Mar 27, 2015 10-Q 2016-05-04
Q4 2014 $1.75B +$201M +13% Dec 26, 2014 10-Q 2016-02-05
Q3 2014 $1.73B +$232M +15.4% Sep 26, 2014 10-K 2017-11-16
Q2 2014 $1.69B +$236M +16.3% Jun 27, 2014 10-Q 2015-07-31
Q1 2014 $1.65B +$245M +17.4% Mar 28, 2014 10-Q 2015-05-06
Q4 2013 $1.55B +$204M +15.2% Dec 27, 2013 10-Q 2015-01-30
Q3 2013 $1.5B -$243M -14% Sep 27, 2013 10-K 2016-11-18
Q2 2013 $1.45B -$301M -17.2% Jun 28, 2013 10-Q 2014-07-30
Q1 2013 $1.41B -$379M -21.2% Mar 29, 2013 10-Q 2014-04-30
Q4 2012 $1.35B -$398M -22.8% Dec 28, 2012 10-Q 2014-01-29
Q3 2012 $1.74B +$57.9M +3.43% Sep 28, 2012 10-K 2015-11-24
Q2 2012 $1.75B +$95.2M +5.75% Jun 29, 2012 10-Q 2013-07-31
Q1 2012 $1.79B +$147M +8.97% Mar 30, 2012 10-Q 2013-05-02
Q4 2011 $1.74B +$172M +11% Dec 30, 2011 10-Q 2013-02-06
Q3 2011 $1.69B +$191M +12.8% Sep 30, 2011 10-K 2014-11-18
Q2 2011 $1.66B +$183M +12.4% Jul 1, 2011 10-Q 2012-08-08
Q1 2011 $1.64B Apr 1, 2011 10-Q 2012-05-08
Q4 2010 $1.57B Dec 31, 2010 10-Q 2012-02-03
Q3 2010 $1.49B Sep 24, 2010 10-K 2013-11-15
Q2 2010 $1.47B Jun 25, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.